Literature DB >> 22130288

Psychonephrology: psychological aspects in autosomal dominant polycystic kidney disease.

T S Pérez Domínguez1, A Rodríguez Pérez, N Buset Ríos, F Rodríguez Esparragón, M A García Bello, P Pérez Borges, Y Parodis López, J C Rodríguez Pérez.   

Abstract

The biological, physical and psychological burden of a chronic disease has an impact on the quality of life of people who suffer from it. The perception of quality of life is affected by psychological disorders such as anxiety and depression that have a high prevalence in people with chronic kidney disease (CKD). These factors are also linked to lower life expectancy. It is therefore surprising that the psychological aspects of people with autosomal dominant polycystic kidney disease (ADPKD) have received so little attention in the medical literature, despite their importance for the overall health of these patients. The relatively new discipline called psychonephrology provides a broader view of the impact that these aspects have on individuals with chronic kidney disease, with a consequent practical application. In this article, we examine the consequences and prevalence of psychological problems that can be related to CKD and ADPKD. Firstly, we will focus on the field of CKD and ADPKD within the scope of psychonephrology. Secondly, the article introduces the concept of quality of life as a basic pillar of health that is affected when a person is diagnosed with CKD. Thirdly, we will present a summary of the main research related to anxiety and depression disorders in CKD and ADPKD. The article will conclude by synthesising findings from the different lines of research undertaken.

Entities:  

Mesh:

Year:  2011        PMID: 22130288     DOI: 10.3265/Nefrologia.pre2011.Jul.10847

Source DB:  PubMed          Journal:  Nefrologia        ISSN: 0211-6995            Impact factor:   2.033


  6 in total

1.  The relationship between depression, anxiety, quality of life levels, and the chronic kidney disease stage in the autosomal dominant polycystic kidney disease.

Authors:  Aysenur Miray Yarlioglu; Ebru Gok Oguz; Ayse Gokcen Gundogmus; Kadir Gokhan Atilgan; Hatice Sahin; Mehmet Deniz Ayli
Journal:  Int Urol Nephrol       Date:  2022-10-02       Impact factor: 2.266

Review 2.  Brain dysfunction in tubular and tubulointerstitial kidney diseases.

Authors:  Davide Viggiano; Annette Bruchfeld; Sol Carriazo; Antonio de Donato; Nicole Endlich; Ana Carina Ferreira; Andreja Figurek; Denis Fouque; Casper F M Franssen; Konstantinos Giannakou; Dimitrios Goumenos; Ewout J Hoorn; Dorothea Nitsch; Alberto Ortiz; Vesna Pešić; Daiva Rastenyté; Maria José Soler; Merita Rroji; Francesco Trepiccione; Robert J Unwin; Carsten A Wagner; Andrzej Wieçek; Miriam Zacchia; Carmine Zoccali; Giovambattista Capasso
Journal:  Nephrol Dial Transplant       Date:  2021-12-28       Impact factor: 5.992

3.  A Systematic Review of Reported Outcomes in ADPKD Studies.

Authors:  Sara S Jdiaa; Nedaa M Husainat; Razan Mansour; Mohamad A Kalot; Kerri McGreal; Fouad T Chebib; Ronald D Perrone; Alan Yu; Reem A Mustafa
Journal:  Kidney Int Rep       Date:  2022-07-05

4.  Understanding the physical and emotional impact of early-stage ADPKD: experiences and perspectives of patients and physicians.

Authors:  Anna Baker; Dominic King; James Marsh; Andrew Makin; Alison Carr; Catherine Davis; Cara Kirby
Journal:  Clin Kidney J       Date:  2015-07-28

5.  Quality of Life and Social Support of People on Peritoneal Dialysis: Mixed Methods Research.

Authors:  Miquel Sitjar-Suñer; Rosa Suñer-Soler; Afra Masià-Plana; Emilia Chirveches-Pérez; Carme Bertran-Noguer; Concepció Fuentes-Pumarola
Journal:  Int J Environ Res Public Health       Date:  2020-06-14       Impact factor: 3.390

6.  Influence of Depression and Anxiety on Hemodialysis Patients: The Value of Multidisciplinary Care.

Authors:  Carlos J Delgado-Domínguez; Sergio Sanz-Gómez; Ana López-Herradón; Beatriz Díaz Espejo; Olaya Lamas González; Macarena de Los Santos Roig; Isabel Berdud Godoy; Abraham Rincón Bello; Rosa Ramos Sánchez
Journal:  Int J Environ Res Public Health       Date:  2021-03-29       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.